BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14475607)

  • 1. The activity of dextro-, levo and racemic furaltadone against infections with Trypanosoma cruzi in Mice.
    MOON AP; COLEMAN JF
    Bol Chil Parasitol; 1962; 17():63-9. PubMed ID: 14475607
    [No Abstract]   [Full Text] [Related]  

  • 2. CHEMOTHERAPY OF EXPERIMENTAL TRYPANOSOMA CRUZI INFECTION IN MICE WITH L-FURALTADONE.
    SENECA H; PEER PM; REGAN JW
    Exp Parasitol; 1964 Dec; 15():479-84. PubMed ID: 14242260
    [No Abstract]   [Full Text] [Related]  

  • 3. [The therapeutic activity of furaltadone, furazolidone and furadantine in experimental infection of the mouse by "Trypanosoma cruzi"].
    BRENER Z
    Hospital (Rio J); 1961 Dec; 60():947-51. PubMed ID: 13872812
    [No Abstract]   [Full Text] [Related]  

  • 4. Preliminary report of 3 cases of Rhodesian sleeping sickness treated with NF-902 (a levo-isomer of furaltadone).
    ADRIAENSSENS K
    Ann Soc Belg Med Trop (1920); 1962 Feb; 42():31-7. PubMed ID: 13859471
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of nitrofurazone on Trypanosoma rhodesiense infections in mice.
    BAKER JR
    Br J Pharmacol Chemother; 1959 Sep; 14(3):408-10. PubMed ID: 13796012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity testing of Staphylococcus aureus with furaltadone.
    KEFAUVER DF; DRUPA I
    Antibiot Chemother (Northfield); 1960 Nov; 10():688-91. PubMed ID: 13752184
    [No Abstract]   [Full Text] [Related]  

  • 7. Furaltadone in the treatment of Rhodesian sleeping sickness.
    ADRIAENSSENS K
    Trop Geogr Med; 1962 Jun; 14():171-82. PubMed ID: 13859470
    [No Abstract]   [Full Text] [Related]  

  • 8. Sensitivity testing of 175 strains of Staphylococcus aureus to furaltadone.
    MANN PH
    Antibiot Chemother (Northfield); 1960 Feb; 10():93-4. PubMed ID: 14420673
    [No Abstract]   [Full Text] [Related]  

  • 9. IMMUNOCHEMISTRY OF TRYPANOSOMA CRUZI AND IMMUNOCHEMOTHERAPY OF EXPERIMENTAL CHAGAS' DISEASE.
    SENECA H; PEER P
    Antimicrob Agents Chemother (Bethesda); 1963; 161():560-5. PubMed ID: 14274961
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the pharmacological properties possessed by a new nitrofuran derivative: Furaltadone].
    DELLA BELLA D; ROGNONI F; VERGA G
    G Ital Chemioter; 1962; 5-9():13-21. PubMed ID: 13885172
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of furaltadone on gastric secretion. Preliminary note].
    MONTALE P; PERIS G; MARCHESE S
    Arch Maragliano Patol Clin; 1962 Jun; 18():371-7. PubMed ID: 14475464
    [No Abstract]   [Full Text] [Related]  

  • 12. Furaltadone-a new systemic antibacterial agent. Statistical review of four hundred and sixty-six cases.
    CHRISTENSON PJ; TRACY CH
    Curr Ther Res Clin Exp; 1960 Jan; 2():22-9. PubMed ID: 13810109
    [No Abstract]   [Full Text] [Related]  

  • 13. [Activity of Nifurmazole (CB 10,615) on Trypanosoma equiperdum, Schizotrypanum cruzi and Trypanosoma gambiense].
    Vindel J; Catalan F; Navarro J; Siou G
    C R Acad Hebd Seances Acad Sci D; 1970 May; 270(20):2512-5. PubMed ID: 4987585
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro activity and mechanism of action against the protozoan parasite Trypanosoma cruzi of 5-nitrofuryl containing thiosemicarbazones.
    Aguirre G; Boiani L; Cerecetto H; Fernández M; González M; Denicola A; Otero L; Gambino D; Rigol C; Olea-Azar C; Faundez M
    Bioorg Med Chem; 2004 Sep; 12(18):4885-93. PubMed ID: 15336268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reaction of the Trypanosoma cruzi strain to the experimental therapeutical response to Bay 2502 (results of long term treatment)].
    Andrade SG; Figueira RM; Carvalho ML; Gorini DF
    Rev Inst Med Trop Sao Paulo; 1975; 17(6):380-9. PubMed ID: 815983
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of nifurtimox on Trypanosoma cruzi in tissue cultures.
    Gönnert R; Bock M
    Arzneimittelforschung; 1972 Sep; 22(9):1582-6. PubMed ID: 4567080
    [No Abstract]   [Full Text] [Related]  

  • 17. Ultrastructural observations on the activity of nifurtimox on the causative organism of Chagas' disease. I. Trypanosoma cruzi in tissue cultures.
    Voigt WH; Bock M; Gönnert R
    Arzneimittelforschung; 1972 Sep; 22(9):1586-9. PubMed ID: 4567081
    [No Abstract]   [Full Text] [Related]  

  • 18. Mode of action of a 5-nitrofuran drug (SQ 18506) against Trypanosoma cruzi.
    Sims P; Gutteridge WE
    Int J Parasitol; 1979 Feb; 9(1):61-7. PubMed ID: 87384
    [No Abstract]   [Full Text] [Related]  

  • 19. Trypanosoma cruzi: a pharmacological comparison of some Bolivian isoenzymic strains.
    Barnabe C; Tibayrenc M; Dujardin JP
    Ann Soc Belg Med Trop; 1983 Dec; 63(4):319-24. PubMed ID: 6198978
    [No Abstract]   [Full Text] [Related]  

  • 20. Furaltadone suppresses IgE-mediated allergic response through the inhibition of Lyn/Syk pathway in mast cells.
    Nam ST; Kim HW; Kim HS; Park YH; Lee D; Lee MB; Min KY; Kim YM; Choi WS
    Eur J Pharmacol; 2018 Jun; 828():119-125. PubMed ID: 29588153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.